© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Biocon to go Ahead with Syngene IPO, Listing Likely in July
Posted 19th May 2015

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biotechnology major Biocon on Wednesday filed a prospectus with market regulator Securities and Exchange Board of India (Sebi) for the Initial Public Offer (IPO) of its research arm, Syngene, through which it aims to raise around Rs 600 crore for funding research and development (R&D).

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biocon to go Ahead with Syngene IPO, Listing Likely in July

View Biography
Amarchand & Mangaldas

Biopharmaceuticals major Biocon on Tuesday said that the unlocking of the value from its contract research subsidiary Syngene would help the company fund its research and development programmes.

Syngene has already filed the draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), seeking approval for an initial public offering (IPO). The company is estimated to be raising around Rs 600 crore through this public issue.

“We are unlocking value from Syngene to fund our R&D programmes, which include a rich pipeline of biosimilars and novel biologics. This fund infusion will help accelerate these programmes which are at various stages of development currently,” said Kiran Mazumdar-Shaw, chairperson and managing director, Biocon.

This is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene. Biocon along with its subsidiary Biocon Research Limited (BRL), currently holds an 84.5 per cent equity stake in Syngene. The company is offering to sell up to 22 million equity shares of face value of Rs 10 each, through Syngene’s IPO.

The offer includes a reservation of two million equity shares for Biocon’s public equity shareholders, being individuals and Hindu Undivided Families (HUFs). The offer would constitute 11 per cent of the post offer paid-up equity share capital of the company.

Established in 1993, Syngene offers a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. The company’s service offerings also support the development of biosimilar and generic molecules.

During the nine months period-ended December 31, 2014, Syngene serviced 195 clients, ranging from multinational corporations to start-ups, including seven of the top 10 global pharmaceutical companies by sales for 2014.

Syngene had reported revenues of Rs 707.7 crore for the previous financial year-ended March 31, 2014 and Rs 617.5 crore for the nine months period ended December 31, 2014. Earlier this month, the company appointed Peter Bains as its Chief Executive Officer. Bains has been a part of Syngene since January 2010 as a director and has more than two decades of experience in the pharmaceutical space.

“Syngene has a proven track record of providing quality NME discovery, development and manufacturing services. It has long-standing partnerships with three of the world’s leading global healthcare organisations, including Bristol-Myers Squibb Co. and has attracted equity participation from India Value Fund recently, which is reflective of the scale, the value and the quality of the differentiated business model of Syngene,” added Mazumdar-Shaw.

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
Knowing Your Audience and Talking to Them Clearly
Strategy
19/10/2020Knowing Your Audience and Talking to Them Clearly

No matter what industry you work in there will be a level of marketing required to be able to reach the right people, and not only reach them but reach them with the right message and the correct language to gain their trust. This means that you are able to bu

Read Full PostRead - Eye Icon
Weld North LLC Completes Merger of Performance Matters and Truenorthlogic
Innovation
Read Full PostRead - Eye Icon
Polaris Acquires Timbersled
M&A
23/04/2015Polaris Acquires Timbersled

Polaris Industries Inc. today announced the acquisition of Timbersled Products, Inc.

Read Full PostRead - Eye Icon
Inside the Codebase: Five Steps of Software Development You Need to Know
News
01/09/2023Inside the Codebase: Five Steps of Software Development You Need to Know

Article written by Valentin Kuzmenko, Chief Commercial Officer/ VP of Sales at Andersen Modern businesses cannot function properly without pioneering software products. Companies willing to get efficient solutions partner with IT providers offering impeccable

Read Full PostRead - Eye Icon
Greenwashing, Social Washing and other Laundry Matters
Leadership
29/10/2020Greenwashing, Social Washing and other Laundry Matters

Across the world businesses are reappraising how they operate and, in many cases, challenging what is really important to their workers.

Read Full PostRead - Eye Icon
Intelligent Storage at the Edge
Innovation
09/10/2023Intelligent Storage at the Edge

Since the emergence of Cloud Computing, there has been an undeniable rise in the risk of data loss. Whether this is a result of a loss of control over how data is managed, or due to potential security breaches that could have detrimental effects on customer da

Read Full PostRead - Eye Icon
Artificial intelligence versus regulation
Leadership
19/07/2018Artificial intelligence versus regulation

As we stand on the threshold of the Fourth Industrial Revolution, the landscape ahead includes developments in areas such as blockchain, internet of things, and nanotechnology

Read Full PostRead - Eye Icon
The Telling Signs of Imposter Syndrome and How to Overcome Them
Leadership
11/03/2024The Telling Signs of Imposter Syndrome and How to Overcome Them

Feeling like a fraud in your professional life is something that many highly successful people battle with. Thoughts of not being good enough, lacking necessary experience, or simply not deserving your success are known popularly as imposter syndrome.

Read Full PostRead - Eye Icon
2016 Intellectual Property Practitioner of the Year – Cameroon
Strategy
31/07/20162016 Intellectual Property Practitioner of the Year – Cameroon

Based in Yaoundé, GAD Consultants provide legal assistance in protection and valorisation of all aspects of IP assets.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow